Wells Fargo Strategic Capital (WFSC), the firm's venture capital arm, focuses on investing in growth-stage companies across diverse sectors, with a strong emphasis on technology and healthcare. Their strategy involves providing capital and strategic support, including non-control equity and private credit, to businesses with strong market potential and scalable models to enhance growth and operational efficiency.
Portfolio
7
Fund Size
—
Top Stage
Series D
Last 12 Mo
0
Team
MR
Matt Raubacher
Managing Director and Division Head of Technology Strategic Capital
Stage Distribution
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| BigPanda | Series E | $20M | Aug 2022 |
| ConcertoCare | Series B | $105M | Feb 2022 |
| Super | Series C | $50M | May 2021 |
| 10x Genomics | Series D | $35M | Jan 2019 |
| R3 | Series D | $107M | May 2017 |
| MSquared | Unknown | — | — |
| Elliptic | Series B | $5M | — |
Top Co-Investors
UBS Next1 shared
SBI Investment1 shared
HSBC1 shared
Intel Capital1 shared
Temasek Holdings1 shared
ING Ventures1 shared
Barclays1 shared
Asahi Kasei1 shared
Gaingels1 shared
Reach Capital1 shared
Aquiline1 shared
Liberty Mutual1 shared
Moderne Ventures1 shared
Goldman Sachs1 shared
Meritech Capital1 shared
Fidelity Investments1 shared
Obvious Ventures1 shared
SteelSky Ventures1 shared
Deerfield1 shared
Last updated: 1 March 2026